⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for fgfr mutation

Every month we try and update this database with for fgfr mutation cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Efficacy and Safety of Pemigatinib in Participants With Solid Tumors With FGFR Mutations or Translocations (FIGHT-208)NCT04003623
Advanced or Met...
FGFR Mutations
FGFR Translocat...
Pemigatinib
18 Years - Incyte Corporation
Biomarker Research Study for Patients With FGFR-Mutant Bladder Cancer Receiving ErdafitinibNCT05052372
Bladder Cancer
Urothelial Carc...
Transitional Ce...
Platinum-Resist...
Bladder Urothel...
FGFR Mutation
FGFR2 Gene Muta...
FGFR3 Gene Muta...
FGFR2 Amplifica...
Locally Advance...
Metastatic Urot...
Refractory Blad...
Refractory Blad...
Balversa
18 Years - xCures
Biomarker Research Study for Patients With FGFR-Mutant Bladder Cancer Receiving ErdafitinibNCT05052372
Bladder Cancer
Urothelial Carc...
Transitional Ce...
Platinum-Resist...
Bladder Urothel...
FGFR Mutation
FGFR2 Gene Muta...
FGFR3 Gene Muta...
FGFR2 Amplifica...
Locally Advance...
Metastatic Urot...
Refractory Blad...
Refractory Blad...
Balversa
18 Years - xCures
Phase 1/2 Study of Derazantinib (ARQ 087) in Adult Subjects With Advanced Solid Tumors With FGFR Genetic AlterationsNCT01752920
Solid Tumor
Derazantinib lo...
Derazantinib mi...
Derazantinib hi...
Derazantinib at...
18 Years - Basilea Pharmaceutica
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: